KEY POINTS:
The US Food and Drug Administration is investigating a possible link between drug company Merck's best-selling Singulair allergy and asthma drug and suicide. The FDA said it was reviewing a handful of reports involving mood changes, suicidal behaviour and suicide in patients who have taken the drug.
